
Celeste A. Roney
Examiner (ID: 19047, Phone: (571)272-5192 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 873 |
| Issued Applications | 472 |
| Pending Applications | 148 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16760946
[patent_doc_number] => 20210106527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => COMPOSITIONS, METHODS AND USES OF MESSENGER RNA
[patent_app_type] => utility
[patent_app_number] => 17/066919
[patent_app_country] => US
[patent_app_date] => 2020-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17066919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/066919 | Compositions, methods and uses of messenger RNA | Oct 8, 2020 | Issued |
Array
(
[id] => 17633852
[patent_doc_number] => 11344557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Corticotropin releasing factor receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 17/063592
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 21440
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063592 | Corticotropin releasing factor receptor antagonists | Oct 4, 2020 | Issued |
Array
(
[id] => 16596460
[patent_doc_number] => 20210022991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => ORAL FILM FORMULATION FOR MODULATING ABSORPTION PROFILE
[patent_app_type] => utility
[patent_app_number] => 17/063644
[patent_app_country] => US
[patent_app_date] => 2020-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17063644
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/063644 | Oral film formulation for modulating absorption profile | Oct 4, 2020 | Issued |
Array
(
[id] => 16939827
[patent_doc_number] => 11052041
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-07-06
[patent_title] => Nanotechnology-based nostril drops for relief of respiratory ailments
[patent_app_type] => utility
[patent_app_number] => 17/060272
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 9210
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060272 | Nanotechnology-based nostril drops for relief of respiratory ailments | Sep 30, 2020 | Issued |
Array
(
[id] => 19700161
[patent_doc_number] => 12194161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Living body-adhesive sheet
[patent_app_type] => utility
[patent_app_number] => 17/033679
[patent_app_country] => US
[patent_app_date] => 2020-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 10229
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17033679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/033679 | Living body-adhesive sheet | Sep 25, 2020 | Issued |
Array
(
[id] => 16568897
[patent_doc_number] => 20210007903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => Analgesic Nose Plugs
[patent_app_type] => utility
[patent_app_number] => 17/031487
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4238
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/031487 | Analgesic Nose Plugs | Sep 23, 2020 | Abandoned |
Array
(
[id] => 18536002
[patent_doc_number] => 20230241089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => STING AGONIST COMPRISING EXOSOMES FOR TREATING NEUROIMMUNOLOGICAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/754177
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754177
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754177 | STING AGONIST COMPRISING EXOSOMES FOR TREATING NEUROIMMUNOLOGICAL DISORDERS | Sep 23, 2020 | Pending |
Array
(
[id] => 16539292
[patent_doc_number] => 20200405705
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => Atropine Pharmaceutical Compositions
[patent_app_type] => utility
[patent_app_number] => 17/016186
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016186
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016186 | Atropine pharmaceutical compositions | Sep 8, 2020 | Issued |
Array
(
[id] => 19075351
[patent_doc_number] => 11944694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Foaming oral care compositions
[patent_app_type] => utility
[patent_app_number] => 17/008684
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18490
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17008684
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/008684 | Foaming oral care compositions | Aug 31, 2020 | Issued |
Array
(
[id] => 18574222
[patent_doc_number] => 11730728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Atropine pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/007900
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11703
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007900 | Atropine pharmaceutical compositions | Aug 30, 2020 | Issued |
Array
(
[id] => 16523659
[patent_doc_number] => 20200397739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/007587
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007587 | SYNERGISTIC COMPOSITION OF VITAMIN C AND VITAMIN K1, AND COMPOSITIONS THEREOF FOR THE TREATMENT OF CANCER | Aug 30, 2020 | Abandoned |
Array
(
[id] => 18574221
[patent_doc_number] => 11730727
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Atropine pharmaceutical compositions
[patent_app_type] => utility
[patent_app_number] => 17/007816
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11711
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007816 | Atropine pharmaceutical compositions | Aug 30, 2020 | Issued |
Array
(
[id] => 17880309
[patent_doc_number] => 20220295786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => BUOYANT ARTICLES COMPRISING LARVICIDES AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/637220
[patent_app_country] => US
[patent_app_date] => 2020-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637220 | BUOYANT ARTICLES COMPRISING LARVICIDES AND METHODS OF USING THE SAME | Aug 20, 2020 | Pending |
Array
(
[id] => 17911204
[patent_doc_number] => 20220313599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => IMPLANTABLE CONSTRUCTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/633716
[patent_app_country] => US
[patent_app_date] => 2020-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633716 | IMPLANTABLE CONSTRUCTS AND USES THEREOF | Aug 6, 2020 | Pending |
Array
(
[id] => 16435597
[patent_doc_number] => 20200352922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-12
[patent_title] => SUSTAINED-RELEASE TOPICALLY ADMINISTERED AGENT
[patent_app_type] => utility
[patent_app_number] => 16/939974
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939974
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939974 | SUSTAINED-RELEASE TOPICALLY ADMINISTERED AGENT | Jul 26, 2020 | Abandoned |
Array
(
[id] => 18018854
[patent_doc_number] => 20220370353
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-11-24
[patent_title] => BLENDED FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/923810
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/923810 | BLENDED FORMULATIONS | Jul 7, 2020 | Abandoned |
Array
(
[id] => 18018854
[patent_doc_number] => 20220370353
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2022-11-24
[patent_title] => BLENDED FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/923810
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28967
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/923810 | BLENDED FORMULATIONS | Jul 7, 2020 | Abandoned |
Array
(
[id] => 20525335
[patent_doc_number] => 12543752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Method for dehydrating liquid, semi-liquid or paste-like products, including a pressure cryogenic step and a lyophilization step
[patent_app_type] => utility
[patent_app_number] => 17/597370
[patent_app_country] => US
[patent_app_date] => 2020-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 3025
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17597370
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/597370 | Method for dehydrating liquid, semi-liquid or paste-like products, including a pressure cryogenic step and a lyophilization step | Jul 5, 2020 | Issued |
Array
(
[id] => 16568986
[patent_doc_number] => 20210007992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => MICROPARTICLE FORMULATIONS OF ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/919614
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16919614
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/919614 | MICROPARTICLE FORMULATIONS OF ADENOSINE RECEPTOR ANTAGONISTS FOR TREATING CANCER | Jul 1, 2020 | Abandoned |
Array
(
[id] => 16523631
[patent_doc_number] => 20200397711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => MICROPARTICLE COMPOSITIONS FOR TREATMENT OF INFECTION OR DISEASE, METHODS OF MAKING THE SAME, AND METHODS OF TREATING SUBJECTS WITH MICROPARTICLE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/908586
[patent_app_country] => US
[patent_app_date] => 2020-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10174
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16908586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/908586 | MICROPARTICLE COMPOSITIONS FOR TREATMENT OF INFECTION OR DISEASE, METHODS OF MAKING THE SAME, AND METHODS OF TREATING SUBJECTS WITH MICROPARTICLE COMPOSITIONS | Jun 21, 2020 | Abandoned |